Maito Suoh

176 Hawkesbury Rd
Westmead, NSW 2145, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Nationwide Trends of Noninvasive Tests for Liver Fibrosis in Japan Between 2014 and 2023.

Nationwide Trends of Noninvasive Tests for Liver Fibrosis in Japan Between 2014 and 2023.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: April 18, 2026

Metabolic liver disease research in the Arab world: a bibliometric analysis of trends, collaborations, and disparities (2006-2024).

Metabolic liver disease research in the Arab world: a bibliometric analysis of trends, collaborations, and disparities (2006-2024).

Journal: Minerva gastroenterology

Published: January 20, 2026

Nationwide Socioeconomic Evaluation of Direct-Acting Antivirals for Chronic Hepatitis C Virus Infection in Japan Between 2014 and 2023.

Nationwide Socioeconomic Evaluation of Direct-Acting Antivirals for Chronic Hepatitis C Virus Infection in Japan Between 2014 and 2023.

Journal: Journal of viral hepatitis

Published: January 17, 2026

Assessing pricing and affordability of HBV treatment in Japan.

Assessing pricing and affordability of HBV treatment in Japan.

Journal: Hepatology international

Published: October 18, 2025

Bile acids mediate liver-bone marrow crosstalk.

Bile acids mediate liver-bone marrow crosstalk.

Journal: iScience

Published: September 18, 2025

Drug pricing for hepatitis B and C in Australia and Japan.

Drug pricing for hepatitis B and C in Australia and Japan.

Journal: Annals of hepatology

Published: August 18, 2025

Reply to "Metabolic (dysfunction)-associated fatty liver disease metrics and contributions: Correspondence".

Reply to "Metabolic (dysfunction)-associated fatty liver disease metrics and contributions: Correspondence".

Journal: Hepatology international

Published: February 20, 2025

Transitions in the nomenclatures for fatty liver disease.

Transitions in the nomenclatures for fatty liver disease.

Journal: Journal of hepatology

Published: December 07, 2024

Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research.

Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research.

Journal: Hepatology international

Published: June 18, 2024

Successful Transcatheter Arterial Embolization for Hemothorax from a Spontaneous Rupture of Hepatocellular Carcinoma Metastasis to the Chest Wall in an Elderly Patient.

Successful Transcatheter Arterial Embolization for Hemothorax from a Spontaneous Rupture of Hepatocellular Carcinoma Metastasis to the Chest Wall in an Elderly Patient.

Journal: Internal medicine (Tokyo, Japan)

Published: February 22, 2021

Obstructive Jaundice Due to Duodenal Ulcer Induced by Lenvatinib Therapy for Hepatocellular Carcinoma.

Obstructive Jaundice Due to Duodenal Ulcer Induced by Lenvatinib Therapy for Hepatocellular Carcinoma.

Journal: Internal medicine (Tokyo, Japan)

Published: October 08, 2020

Early Change in the Plasma Levels of Circulating Soluble Immune Checkpoint Proteins in Patients with Unresectable Hepatocellular Carcinoma Treated by Lenvatinib or Transcatheter Arterial Chemoembolization.

Early Change in the Plasma Levels of Circulating Soluble Immune Checkpoint Proteins in Patients with Unresectable Hepatocellular Carcinoma Treated by Lenvatinib or Transcatheter Arterial Chemoembolization.

Journal: Cancers

Published: June 25, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026